Jaime Davidson, MD

Jaime Davidson, MD, FACP, MACE
 

Clinical Professor of Medicine
Division of Endocrinology, Diabetes and Metabolism
University of Texas Southwestern Medical School
Dallas, TX


What is the rationale for combining a basal insulin and GLP-1 RA in a fixed-ratio formulation?

What is the rationale for combining a basal insulin and GLP-1 RA in a fixed-ratio formulation?

From a practical perspective, how should clinicians titrate the fixed-ratio combinations such a iDegLira and iGlarLixi?

From a practical perspective, how should clinicians titrate the fixed-ratio combinations such a iDegLira and iGlarLixi?

What patients with T2D are most likely to benefit from fixed-ratio combinations such a iDegLira and iGlarLixi?

What patients with T2D are most likely to benefit from fixed-ratio combinations such a iDegLira and iGlarLixi?